These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 365798)

  • 1. Analysis of a certain type of 2 x 3 tables, exemplified by biopsy findings in a controlled clinical trial.
    Scheiber V; Wohlzogen FX
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):533-5. PubMed ID: 365798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
    Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
    Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of two double-blind studies on the effect of silymarine in chronic hepatitis (author's transl)].
    Kiesewetter E; Leodolter I; Thaler H
    Leber Magen Darm; 1977 Oct; 7(5):318-23. PubMed ID: 926982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients].
    Trinchet JC; Coste T; Lévy VG; Vivet F; Duchatelle V; Legendre C; Gotheil C; Beaugrand M
    Gastroenterol Clin Biol; 1989; 13(2):120-4. PubMed ID: 2707520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Romanian product Silimarina in the treatment of chronic liver diseases.
    Tănăsescu C; Petrea S; Băldescu R; Macarie E; Chiriloiu C; Purice S
    Med Interne; 1988; 26(4):311-22. PubMed ID: 3072661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levamisole therapy in chronic hepatitis--results of a multicentric double blind trial.
    Nilius R; Schentke U; Otto L; Teichmann W; Zipprich B; Schmidt W; Brügmann E; Busse HJ
    Hepatogastroenterology; 1983 Jun; 30(3):90-2. PubMed ID: 6350136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 8. [Principles of controlled trials (author's transl)].
    Fink H
    Arzneimittelforschung; 1978; 28(11a):2017-9. PubMed ID: 383091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panel discussion on clinical trials: design.
    Forssman L
    Rheumatol Rehabil; 1978; Suppl():126-8. PubMed ID: 364603
    [No Abstract]   [Full Text] [Related]  

  • 10. [The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)].
    Benda L; Dittrich H; Ferenzi P; Frank H; Wewalka F
    Wien Klin Wochenschr; 1980 Oct; 92(19):678-83. PubMed ID: 7008367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative to the use of two-sided tests in clinical trials.
    Dunnett CW; Gent M
    Stat Med; 1996 Aug; 15(16):1729-38. PubMed ID: 8870155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Controlled study of the effect of silymarin on alcoholic liver disease].
    Bunout D; Hirsch S; Petermann M; de la Maza MP; Silva G; Kelly M; Ugarte G; Iturriaga H
    Rev Med Chil; 1992 Dec; 120(12):1370-5. PubMed ID: 1343377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues in designing and interpreting clinical trials of treatments for chronic hepatitis C.
    O'Brien C
    J Viral Hepat; 2006 May; 13 Suppl 1():6-14. PubMed ID: 16630042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial with arginine tidiacicate in symptomatic chronic persistent hepatitis.
    Rizzo S
    Int J Clin Pharmacol Res; 1986; 6(3):225-30. PubMed ID: 3527997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of citiolone in chronic hepatitides. Results of a research with clinical and laboratory controls].
    Miglio F; D'Ambro A; Stefanini GF; Corazza GR; Pesa O; Flacco L; Schiavone C; Gasbarrini G
    Minerva Med; 1977 Sep; 68(46):3177-92. PubMed ID: 917333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics of forms of chronic hepatitis].
    Markiewicz K; Bubiński R
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(2):76-82. PubMed ID: 4006842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial.
    Porter HP; Simon FR; Pope CE; Volwiler W; Fenster LF
    N Engl J Med; 1971 Jun; 284(24):1350-5. PubMed ID: 4930603
    [No Abstract]   [Full Text] [Related]  

  • 18. [The "paired cards" system. A practical and generally applicable procedure for the clinical trial of drugs (author's transl)].
    Schenck EG; Kirchert W
    Arzneimittelforschung; 1978; 28(1a):192. PubMed ID: 580218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple practice research. Experience with some methods].
    Bennedsen H; Nielsen JV
    Ugeskr Laeger; 1979 May; 141(22):1482-4. PubMed ID: 377745
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
    Gharagozloo M; Moayedi B; Zakerinia M; Hamidi M; Karimi M; Maracy M; Amirghofran Z
    Fundam Clin Pharmacol; 2009 Jun; 23(3):359-65. PubMed ID: 19453758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.